Shorla Oncology Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 81927 (Shorla Oncology Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
7
Package NDCs
8
Products
6
Active listings
2
Discontinued
4
Ingredients
0
Therapeutic classes
2
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 8 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| IMKELDI imatinib oral 80 mg/mL SOLUTION | 81927-0201-01 | — | On market | View → |
| JYLAMVO Methotrexate 2 mg/mL SOLUTION | 81927-0204-01 | — | On market | View → |
| nelarabine 5 mg/mL INJECTION | 81927-0111-01 | — | On market | View → |
| nelarabine 5 mg/mL INJECTION | 81927-0375-01 | — | On market | View → |
| TEPYLUTE thiotepa 10 mg/mL INJECTION | 81927-0105-01 | — | Discontinued | View → |
| TEPYLUTE thiotepa 10 mg/mL INJECTION | 81927-0106-01 | — | Discontinued | View → |
| TEPYLUTE thiotepa 10 mg/mL INJECTION | 81927-0106-01 | — | Discontinued | View → |
| TEPYLUTE thiotepa 10 mg/mL INJECTION | 81927-0105-01 | — | Discontinued | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.